ZWJ Investment Counsel’s Novartis NVS Stock Holding History

ZWJ Investment Counsel’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,202	Closed	-$316K	–	238
2017 Q4	$316K	Buy	4,202 +149	+4%	+$11.2K	0.03%	221
2017 Q3	$312K	Buy	4,053 +632	+18%	+$47.7K	0.02%	213
2017 Q2	$256K	Sell	3,421 -140	-4%	-$9.92K	0.02%	255
2017 Q1	$237K	Buy	+3,561	New	+$237K	0.02%	284

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ZWJ Investment Counsel's NVS Position: Q1 2018 in Review

ZWJ Investment Counsel sold out of Novartis (NVS) in Q1 2018, closing a stake of 4,202 shares — an estimated $316K sold.

ZWJ Investment Counsel first reported a position in NVS in Q1 2017 and held it in 4 quarters. The position peaked at $316K in Q4 2017. 1,013 funds tracked by Wall St. Rank hold NVS as of Q1 2018.

ZWJ Investment Counsel reported no remaining Novartis position as of Q1 2018 after selling out during the quarter.
ZWJ Investment Counsel sold 4,202 Novartis shares in Q1 2018, an estimated $316K.
ZWJ Investment Counsel first reported a position in Novartis in Q1 2017 and held it in 4 quarters.
ZWJ Investment Counsel's Novartis position peaked at $316K in Q4 2017.
1,013 funds tracked by Wall St. Rank held Novartis as of Q1 2018.

Based on ZWJ Investment Counsel's 13F filing for Q1 2018, filed 24 Apr 2018.